CATALOGO DEI PRODOTTI DELLA RICERCA

LANZAFAME, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.117
EU - Europa 2.929
AS - Asia 2.053
SA - Sud America 302
AF - Africa 69
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.480
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.036
RU - Federazione Russa 1.150
SG - Singapore 865
CN - Cina 593
GB - Regno Unito 529
BR - Brasile 250
IT - Italia 245
SE - Svezia 195
VN - Vietnam 184
DE - Germania 176
IE - Irlanda 161
FR - Francia 149
HK - Hong Kong 149
FI - Finlandia 131
KR - Corea 66
CA - Canada 44
UA - Ucraina 43
IN - India 34
JP - Giappone 34
ZA - Sudafrica 26
AR - Argentina 25
PL - Polonia 24
MX - Messico 23
NL - Olanda 22
CZ - Repubblica Ceca 21
TR - Turchia 20
BD - Bangladesh 19
ID - Indonesia 18
IQ - Iraq 15
NG - Nigeria 15
BE - Belgio 14
ES - Italia 12
AT - Austria 10
CO - Colombia 10
BF - Burkina Faso 8
UZ - Uzbekistan 8
LT - Lituania 7
PK - Pakistan 7
SA - Arabia Saudita 7
CL - Cile 6
PH - Filippine 6
RO - Romania 6
AU - Australia 5
CH - Svizzera 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EG - Egitto 4
GR - Grecia 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
EC - Ecuador 3
GT - Guatemala 3
HR - Croazia 3
HU - Ungheria 3
IL - Israele 3
KE - Kenya 3
MA - Marocco 3
MY - Malesia 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PE - Perù 2
PY - Paraguay 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BJ - Benin 1
CD - Congo 1
DZ - Algeria 1
GY - Guiana 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TG - Togo 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
ZW - Zimbabwe 1
Totale 8.480
Salva come PNG Salva come JPEG
Città #
Singapore 490
Southend 416
Moscow 409
Chandler 389
Ashburn 291
San Jose 283
Jacksonville 245
Woodbridge 234
Dallas 194
Dublin 160
Hong Kong 147
Ann Arbor 140
Beijing 120
Verona 94
New York 76
The Dalles 72
Los Angeles 70
Ho Chi Minh City 58
Lawrence 53
Princeton 53
Helsinki 48
Houston 46
Jinan 45
Munich 45
Nanjing 44
Shenyang 43
Wilmington 43
Hanoi 37
Tokyo 31
Santa Clara 29
São Paulo 29
Council Bluffs 25
Warsaw 24
Buffalo 23
Hebei 21
London 20
Turku 20
Atlanta 19
Denver 19
Frankfurt am Main 19
Orem 19
Tianjin 19
Brno 18
Montreal 18
Boardman 16
Bologna 16
Redondo Beach 16
Seoul 16
Toronto 16
Ningbo 15
Zhengzhou 15
Abuja 14
Brussels 14
Haikou 14
Johannesburg 14
Bloomsbury 13
Sindelfingen 13
Changsha 12
Amsterdam 11
Chennai 11
Guangzhou 11
Hangzhou 11
Milan 11
Nanchang 11
Phoenix 11
San Francisco 11
Taizhou 11
Boston 10
Columbus 10
Jiaxing 10
Redmond 10
Seattle 10
Stockholm 10
Jakarta 9
Norwalk 9
Redwood City 9
Rio de Janeiro 9
Brooklyn 8
Da Nang 8
Dong Ket 8
Fuzhou 8
Haiphong 8
Ouagadougou 8
Baghdad 7
Clearwater 7
Lanzhou 7
Manchester 7
Nuremberg 7
Poplar 7
Tashkent 7
Belo Horizonte 6
Chicago 6
City of London 6
Falls Church 6
Mumbai 6
Taiyuan 6
Washington 6
Curitiba 5
Madrid 5
Mexico City 5
Totale 5.251
Salva come PNG Salva come JPEG
Nome #
Performance of alere determine HIV-1/2 Ag/Ab combo rapid test for acute HIV infection: A case report | Performance del test rapido Alere Determine HIV-1/2 Ag/Ab Combo nell?infezione acuta da HIV: Un caso clinic 243
Benign acute viral myositis in African migrants: a clinical, serological and pathological study. 240
Cryptococcal dermatitis with negative antigenaemia heralding disseminated disease in HIV infection. 215
HIV-1-associated neurocognitive disorders: is HLA-C binding stability to β2-microglobulin a missing piece of the pathogenetic puzzle? 211
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 209
Disseminated Mycobacterium chimaera infection after open heart surgery in an Italian woman: a case report and a review of the literature 203
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report. 197
Pneumatocoele formation during Pneumocystis carinii pneumonia in a man with HIV-1 infection. 188
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 185
'High' antiretroviral deintensification strategy and cellular HIV DNA levels 185
Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up 184
Successful Antifungal Combination Therapy and Surgical Approach for Aspergillus fumigatus Suppurative Thyroiditis Associated with Thyrotoxicosis and Review of Published Reports 182
Histoplasmosis in two human immunodeficiency virus-positive immigrants to Italy: clinical features and management in the highly active antiretroviral therapy era. 177
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 177
Primary cutaneous cryptococcosis in a HIV infested patient: case report. 173
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 173
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients 171
Is there a role for TNF-alpha in HIV1-associated lipodystrophy? 170
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 168
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 168
No improvement of lipodystrophy syndrome in an HIV-infected patient. 165
Can we really identify HIV-1 long-term nonprogressors? 163
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 163
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption. 161
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 161
Short-Cycle Therapy (5 days on/2 days off) with a lamivudine-dolutegravir two-drug regimen in a cohort of virologically suppressed HIV-infected patients 161
Recreational substance use and tolerance of efavirenz in HIV-1 infected patients 158
Monoclonal gammopathy in HIV-Infected patients on stable antiretroviral therapy: disappearance or deep reduction? 157
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report 156
Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report. 154
Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and Hepatitis B and C-infected patients treated with ART 150
Efficacy and safety of TAM-sparing antiretroviral regimens in naive HIV-positive patients 147
Unusual rapidly growing ulcerative genital mass due to herpes simplex virus in uman immunodeficiency virus-infected woman 145
Oxaliplatin Based Chemotherapy and Concomitant Highly Active Antiretroviral Therapy in the Treatment of 24 Patients with Colorectal Cancer and HIV Infection 144
Antiretroviral therapy in low-resource settings 143
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients 139
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials 138
Prevalence of Strongyloides stercoralis infection among HIV-positive immigrants attending two Italian hospitals, from 2000 to 2009. 136
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 135
Efavirenz dose reduction in HIV-infected patients: a long-term follow-up 132
Disappearance of Renal Stones in an HIV-1-Infected Patient After Reduction of Atazanavir Dose 128
The treatment of latent TB infection in HIV-positive people: the Verona experience 127
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings 127
Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up 126
Inflammatory pseudotumor of lymph nodes. 124
Raltegravir: is a 400 mg once-daily dose enough? 123
Quantitative Trait Loci for CD4:CD8 Lymphocyte Ratio Are Associated with Risk of Type 1 Diabetes and HIV-1 Immune Control 122
Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected women. 119
The major genetic determinants of HIV-1 control affect HLA Class I Peptide presentation 119
Budget impact analysis of efavirenz daily dose reduction at the Verona University Hospital 113
No influence of nevirapine on vitamin D deficiency in HIV-infected patients 104
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 102
Pharmacokinetic exposure and virological efficacy of a reduced atazanavir dose. 85
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy 81
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study 69
WISE (Web-based Infectious Support for the Elderly) Initiative: Improving Infectious Disease Management in LTCFs-Experience From Northern Italy 32
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 23
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 21
Totale 8.572
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.179
article - articoli 27.099
book - libri 0
conference - conferenze 80
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.358
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202188 0 0 0 0 0 0 0 0 0 19 46 23
2021/2022489 44 151 4 66 6 8 5 22 26 15 32 110
2022/20231.035 58 137 83 164 100 256 3 71 122 6 20 15
2023/2024486 26 45 52 39 63 84 6 26 6 28 63 48
2024/20251.148 59 81 37 175 59 27 66 39 184 71 105 245
2025/20263.620 256 200 188 637 1.038 258 312 165 341 225 0 0
Totale 8.572